WADE JEFFREY L
Insider CIK 1225767 · LXRX President and COO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-07-08 | 2024-07-08 | 307,000 | — | $0 | 307,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-02-28 | 2024-02-29 | 37,274 | — | $0 | 37,273 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-02-28 | 2024-02-29 | 11,177 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-02-28 | 2024-02-29 | 49,113 | — | $0 | 98,227 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-02-28 | 2024-02-29 | 49,113 | — | $0 | 361,905 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-02-28 | 2024-02-29 | 11,177 | — | $0 | 275,518 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-02-28 | 2024-02-29 | 37,274 | — | $0 | 312,792 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2024-02-28 | 2024-02-29 | 37,691 | $2.62 | $98.8K | 324,214 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-02-08 | 2024-02-12 | 314,320 | — | $0 | 314,320 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-02-08 | 2024-02-12 | 314,320 | — | $0 | 314,320 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2023-09-14 | 2023-09-14 | 10,000 | $1.38 | $13.8K | 264,341 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2023-06-20 | 2023-06-20 | 10,000 | $2.34 | $23.4K | 252,341 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2023-06-20 | 2023-06-20 | 2,000 | $2.33 | $4.7K | 254,341 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2023-02-28 | 2023-03-01 | 11,176 | — | $0 | 11,177 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2023-02-28 | 2023-03-01 | 30,467 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2023-02-28 | 2023-03-01 | 37,273 | — | $0 | 74,547 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2023-02-28 | 2023-03-01 | 30,255 | $2.17 | $65.7K | 242,341 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2023-02-28 | 2023-03-01 | 37,273 | — | $0 | 272,596 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2023-02-28 | 2023-03-01 | 11,176 | — | $0 | 235,323 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2023-02-28 | 2023-03-01 | 30,467 | — | $0 | 224,147 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2023-02-09 | 2023-02-13 | 147,340 | — | $0 | 147,340 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2023-02-09 | 2023-02-13 | 442,030 | — | $0 | 442,030 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2022-02-28 | 2022-02-28 | 30,466 | — | $0 | 30,467 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2022-02-28 | 2022-02-28 | 25,290 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2022-02-28 | 2022-02-28 | 11,177 | — | $0 | 22,353 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2022-02-28 | 2022-02-28 | 25,773 | $2.85 | $73.5K | 193,680 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2022-02-28 | 2022-02-28 | 11,177 | — | $0 | 219,453 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2022-02-28 | 2022-02-28 | 30,466 | — | $0 | 208,276 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2022-02-28 | 2022-02-28 | 25,290 | — | $0 | 177,810 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2022-02-10 | 2022-02-14 | 335,470 | — | $0 | 335,470 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2022-02-10 | 2022-02-14 | 111,820 | — | $0 | 111,820 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 30,467 | — | $0 | 60,933 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 25,290 | — | $0 | 25,290 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 9,555 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 2,797 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 25,290 | — | $0 | 153,137 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 2,797 | — | $0 | 118,292 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 9,555 | — | $0 | 127,847 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 30,467 | — | $0 | 183,604 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2021-02-28 | 2021-03-02 | 26,584 | $7.19 | $191.1K | 157,020 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2021-02-11 | 2021-02-16 | 33,530 | — | $0 | 33,530 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2021-02-11 | 2021-02-16 | 100,600 | — | $0 | 100,600 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2020-04-22 | 2020-04-24 | 9,651 | $1.96 | $18.9K | 115,495 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2020-04-22 | 2020-04-24 | 26,525 | — | $0 | 125,146 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 25,290 | — | $0 | 50,580 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 4,495 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 2,798 | — | $0 | 2,797 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 9,555 | — | $0 | 9,555 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 4,495 | — | $0 | 77,003 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 2,798 | — | $0 | 79,801 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 9,555 | — | $0 | 89,356 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 25,290 | — | $0 | 114,646 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2020-02-28 | 2020-03-03 | 16,025 | $2.77 | $44.4K | 98,621 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2020-02-06 | 2020-02-10 | 91,400 | — | $0 | 91,400 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2020-02-06 | 2020-02-10 | 274,200 | — | $0 | 274,200 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 4,495 | — | $0 | 4,495 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 5,807 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 9,555 | — | $0 | 19,110 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 2,798 | — | $0 | 5,595 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 9,555 | — | $0 | 81,147 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2019-02-28 | 2019-03-01 | 8,639 | $5.51 | $47.6K | 72,508 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 5,807 | — | $0 | 64,299 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 4,495 | — | $0 | 68,794 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 2,798 | — | $0 | 71,592 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2019-02-07 | 2019-02-08 | 140,900 | — | $0 | 140,900 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2019-02-07 | 2019-02-08 | 75,870 | — | $0 | 75,870 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 5,807 | — | $0 | 5,807 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 4,495 | — | $0 | 8,990 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 2,797 | — | $0 | 8,393 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 2,929 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2018-02-28 | 2018-03-02 | 6,133 | $8.53 | $52.3K | 59,492 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 2,929 | — | $0 | 52,526 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 5,807 | — | $0 | 58,333 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 2,797 | — | $0 | 65,625 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 4,495 | — | $0 | 62,828 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2018-02-08 | 2018-02-12 | 28,665 | — | $0 | 28,665 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2018-02-08 | 2018-02-12 | 79,550 | — | $0 | 79,550 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-11-14 | 2017-11-14 | 2,000 | $9.48 | $19.0K | 50,597 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2017-02-28 | 2017-03-01 | 4,495 | — | $0 | 13,485 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2017-02-28 | 2017-03-01 | 5,807 | — | $0 | 11,614 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2017-02-28 | 2017-03-01 | 2,928 | — | $0 | 2,929 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2017-02-28 | 2017-03-01 | 2,429 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2017-02-28 | 2017-03-01 | 6,455 | $16.45 | $106.2K | 48,597 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2017-02-28 | 2017-03-01 | 5,807 | — | $0 | 50,557 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2017-02-28 | 2017-03-01 | 2,928 | — | $0 | 44,750 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2017-02-28 | 2017-03-01 | 2,429 | — | $0 | 41,822 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2017-02-28 | 2017-03-01 | 4,495 | — | $0 | 55,052 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2017-02-09 | 2017-02-13 | 11,190 | — | $0 | 11,190 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2017-02-09 | 2017-02-13 | 44,770 | — | $0 | 44,770 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-02-29 | 2016-03-02 | 5,807 | — | $0 | 17,421 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-02-29 | 2016-03-02 | 2,428 | — | $0 | 2,429 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-02-29 | 2016-03-02 | 2,785 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-02-29 | 2016-03-02 | 2,929 | — | $0 | 5,857 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2016-02-29 | 2016-03-02 | 3,815 | $9.07 | $34.6K | 39,393 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-02-29 | 2016-03-02 | 5,807 | — | $0 | 43,208 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-02-29 | 2016-03-02 | 2,929 | — | $0 | 37,401 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-02-29 | 2016-03-02 | 2,428 | — | $0 | 34,472 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-02-29 | 2016-03-02 | 2,785 | — | $0 | 32,044 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2016-02-11 | 2016-02-16 | 71,940 | — | $0 | 71,940 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2016-02-11 | 2016-02-16 | 17,980 | — | $0 | 17,980 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2015-03-02 | 2015-03-03 | 19,500 | — | $0 | 19,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2015-03-02 | 2015-03-03 | 17,000 | — | $0 | 34,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2015-03-02 | 2015-03-03 | 20,500 | — | $0 | 61,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2015-03-02 | 2015-03-03 | 18,750 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2015-03-02 | 2015-03-03 | 18,750 | — | $0 | 168,539 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2015-03-02 | 2015-03-03 | 19,500 | — | $0 | 188,039 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2015-03-02 | 2015-03-03 | 17,000 | — | $0 | 205,039 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2015-03-02 | 2015-03-03 | 20,500 | — | $0 | 225,539 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2015-03-02 | 2015-03-03 | 20,718 | $0.94 | $19.5K | 204,821 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2015-02-05 | 2015-02-09 | 162,600 | — | $0 | 162,600 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2015-02-05 | 2015-02-09 | 650,400 | — | $0 | 650,400 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2014-02-28 | 2014-03-03 | 19,500 | — | $0 | 39,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2014-02-28 | 2014-03-03 | 17,000 | — | $0 | 51,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2014-02-28 | 2014-03-03 | 18,750 | — | $0 | 18,750 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2014-02-28 | 2014-03-03 | 16,297 | $1.92 | $31.3K | 149,789 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2014-02-28 | 2014-03-03 | 17,000 | — | $0 | 166,086 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2014-02-28 | 2014-03-03 | 19,500 | — | $0 | 149,086 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2014-02-28 | 2014-03-03 | 18,750 | — | $0 | 129,586 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2014-02-06 | 2014-02-10 | 328,000 | — | $0 | 328,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2014-02-06 | 2014-02-10 | 82,000 | — | $0 | 82,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2013-02-28 | 2013-03-01 | 19,500 | — | $0 | 58,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2013-02-28 | 2013-03-01 | 18,750 | — | $0 | 37,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2013-02-28 | 2013-03-01 | 10,461 | $1.98 | $20.7K | 110,836 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2013-02-28 | 2013-03-01 | 18,750 | — | $0 | 101,797 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2013-02-28 | 2013-03-01 | 19,500 | — | $0 | 121,297 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2013-02-08 | 2013-02-12 | 272,000 | — | $0 | 272,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2013-02-08 | 2013-02-12 | 68,000 | — | $0 | 68,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2013-01-31 | 2013-02-04 | 31,600 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2013-01-31 | 2013-02-04 | 10,317 | $2.11 | $21.8K | 83,047 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2013-01-31 | 2013-02-04 | 31,600 | — | $0 | 93,364 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2012-02-28 | 2012-03-01 | 18,750 | — | $0 | 56,250 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2012-02-28 | 2012-03-01 | 4,959 | $1.78 | $8.8K | 61,764 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2012-02-28 | 2012-03-01 | 18,750 | — | $0 | 66,723 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2012-02-15 | 2012-02-17 | 312,000 | — | $0 | 312,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2012-02-15 | 2012-02-17 | 78,000 | — | $0 | 78,000 | SEC↗ |